From Investment to Deployment: Why Intellectual Property Matters in an Expanding Nuclear Energy Market
Key Takeaway: New federal initiatives are expanding access to private capital and deployment financing for nuclear energy technologies. Companies that fail to protect and clearly document their intellectual property may...
FDA Announces New Rare Disease Framework With Potential Implications for IP Strategy
Key Takeaway: On October 14, 2026, the FDA announced a proposed framework for rare disease drug development that aims to provide greater regulatory flexibility and disease-tailored evaluation. Increased regulatory clarity...
Aerospace Vertical Integration: Turning Manufacturing Control Into an IP Advantage
Key Takeaways: Vertical integration and in-house manufacturing can provide aerospace companies with greater control over supply chains and manufacturing capacity while creating new opportunities for innovation. To maximize the value...